Understand the source comparison
Best Peptides for Senescent Cell Removal: Mechanism Comparison
FOXO4-DRI Disrupts FOXO4-p53 interaction, restoring p53-mediated apoptosis in senescent cells High. 70% senescent cell death vs <5% in proliferating cells (2017 Cell study) Strong. Phase 1 human data published 2020 7–14 days for measurable senescent cell reduc
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- FOXO4-DRI
- Disrupts FOXO4-p53 interaction, restoring p53-mediated apoptosis in senescent cells
- High. 70% senescent cell death vs <5% in proliferating cells (2017 Cell study)
- Strong. Phase 1 human data published 2020
- 7–14 days for measurable senescent cell reduction
- Most mechanistically specific senolytic identified. Gold standard for apoptosis-based clearance research
- Thymalin
- Upregulates T-cell and NK-cell activity, enhancing immune-mediated senescent cell clearance
- Moderate. Depends on baseline immune function and senescent cell immunogenicity
- Moderate. Multiple murine aging studies, limited human senescence data
- 4–8 weeks for immune reconstitution and clearance
- Best for immune-compromised models where surveillance is the limiting factor. Indirect but physiologically relevant
- Humanin
- Prevents mitochondrial dysfunction in healthy cells while triggering apoptosis in cells with depolarized mitochondria
- Moderate. Selective for mitochondrially damaged populations, not all senescent phenotypes
- Moderate. Preclinical data strong, mechanism well-characterized
- 2–3 weeks for mitochondrial remodeling effects
- Dual benefit. Protects healthy mitochondria while clearing dysfunctional cells; ideal for metabolic aging models
- Epithalon
- Telomerase activation and circadian normalization reduce replicative senescence
- Low. Prevents senescence onset more than clearing existing senescent cells
- Weak. Limited peer-reviewed data, mostly observational studies
- 8–12 weeks for telomere-length changes
- Prophylactic rather than senolytic. Reduces future burden but limited acute clearance capacity